User profiles for A. Olson

Arthur Olson

- Verified email at scripps.edu - Cited by 96608

Ĺke Olson

- Verified email at slu.se - Cited by 4820

Automated docking of flexible ligands: applications of AutoDock

…, GM Morris, AJ Olson - Journal of molecular …, 1996 - Wiley Online Library
AutoDock is a suite of C programs used to predict the bound conformations of a small, flexible
ligand to a macromolecular target of known structure. The technique combines simulated …

Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management

…, LE Case, L Cripe, S Hadjiyannakis, AK Olson… - The Lancet …, 2018 - thelancet.com
A coordinated, multidisciplinary approach to care is essential for optimum management of
the primary manifestations and secondary complications of Duchenne muscular dystrophy (…

Structural symmetry and protein function

DS Goodsell, AJ Olson - Annual review of biophysics and …, 2000 - annualreviews.org
▪ Abstract The majority of soluble and membrane-bound proteins in modern cells are
symmetrical oligomeric complexes with two or more subunits. The evolutionary selection of …

[HTML][HTML] Structural and functional conservation of the programmed− 1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2)

JA Kelly, AN Olson, K Neupane, S Munshi… - Journal of Biological …, 2020 - ASBMB
Approximately 17 years after the severe acute respiratory syndrome coronavirus (SARS-CoV)
epidemic, the world is currently facing the COVID-19 pandemic caused by SARS corona …

Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline

…, B Crestani, L Ho, J Morisset, AL Olson… - American Journal of …, 2022 - atsjournals.org
Background: This American Thoracic Society, European Respiratory Society, Japanese
Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior …

ABT-888, an orally active poly (ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models

…, TP McGonigal, JA Meulbroek, AM Olson… - Clinical cancer …, 2007 - AACR
Purpose: To evaluate the preclinical pharmacokinetics and antitumor efficacy of a novel
orally bioavailable poly(ADP-ribose) polymerase (PARP) inhibitor, ABT-888. Experimental …

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

…, RK Belew, DS Goodsell, AJ Olson - Journal of …, 2009 - Wiley Online Library
We describe the testing and release of AutoDock4 and the accompanying graphical user
interface AutoDockTools. AutoDock4 incorporates limited flexibility in the receptor. Several …

Reduced surface: an efficient way to compute molecular surfaces

MF Sanner, AJ Olson, JC Spehner - Biopolymers, 1996 - Wiley Online Library
Because of their wide use in molecular modeling, methods to compute molecular surfaces
have received a lot of interest in recent years. However, most of the proposed algorithms …

[HTML][HTML] Infliximab for induction and maintenance therapy for ulcerative colitis

…, BG Feagan, W Reinisch, A Olson… - … England Journal of …, 2005 - Mass Medical Soc
Background Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor
α, is an established treatment for Crohn's disease but not ulcerative colitis. Methods Two …

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

…, JF Colombel, D Rachmilewitz, DC Wolf, A Olson… - The Lancet, 2002 - thelancet.com
Background We did a randomised controlled trial to assess the benefit of maintenance
infliximab therapy in patients with active Crohn's disease who respond to a single infusion of …